SMITH & NEPHEW PLC ORD USD0.20
Stock London Stock Exchange – Stock Market Prices, News & Analysis
Smith & Nephew est une entreprise spécialisée dans la fabrication et la commercialisation de dispositifs médicaux, principalement dans les domaines de l'orthopédie, de la chirurgie des plaies et de l'endoscopie.
SMITH & NEPHEW PLC ORD USD0.20
Smith & Nephew est une entreprise spécialisée dans la fabrication et la commercialisation de dispositifs médicaux, principalement dans les domaines de l'orthopédie, de la chirurgie des plaies et de l'endoscopie.
Price history of SMITH & NEPHEW PLC ORD USD0.20
Price history of SMITH & NEPHEW PLC ORD USD0.20
Performance & Momentum
Strategic Analysis
SMITH & NEPHEW PLC ORD USD0.20 • 2026
Smith & Nephew positions itself as a specialized player in orthopedic and surgical medical devices, focusing on innovation in medical technologies to meet the growing needs of the aging population. Its business model is based on a diversification between orthopedics, wound care, and endoscopy, which gives it a solid niche in a defensive sector with high technological barriers.
Strengths
- Recognized expertise in orthopedic devices and high-quality prosthetics
- Diversified portfolio covering multiple medical segments related to surgery
- Consolidated geographic presence in the United Kingdom with international reach
Weaknesses
- Volatile performance in the medium term reflecting exposure to hospital investment cycles
- Strong competitive pressure on innovative technologies and margins
Momentum
The current moderate momentum reflects a renewed interest from investors following a slight recent correction. The one-year momentum highlights an encouraging recovery, supported by the strength of its sector positioning, although multi-year performance remains under pressure, suggesting caution regarding competitive evolution and ongoing innovation.
Similar stocks to SMITH & NEPHEW PLC ORD USD0.20
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases